Andrew Cheng - 02 Jan 2024 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Signature
Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
02 Jan 2024
Net transactions value
+$24,600
Form type
4
Filing time
03 Jan 2024, 17:00:09 UTC
Previous filing
18 Dec 2023
Next filing
06 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $24,600 +40,000 +7.3% $0.6150 590,911 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -40,000 -62% $0.000000 24,538 02 Jan 2024 Common Stock 40,000 $0.6150 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable.